Skip to main content

Want a detailed portfolio tracker?

Cingulate (CING) P/E (2021 - 2026)

Cingulate (CING) P/E from Dec 31, 2021 to Jul 21, 2026. The TTM Cingulate (CING) P/E is -1.23. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cingulate (CING)

YearP/EChange
2026-1.23+16.37%
2025-1.05+208.74%
2024-0.34-92.61%
2023-4.62-67.86%
2022-14.38-93.89%
2021-235.48N/A

Comparison Cingulate (CING) P/E with competitors

Cingulate (CING) P/E is -1.23.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.35%
ENLVEnlivex Ltd0.07-106.10%
FGENFibroGen Inc0.24-119.57%
CHRSCoherus Biosciences Inc0.85-169.18%
FBIOFortress Biotech Inc0.95-177.37%
ORMPOramed Pharmaceuticals Inc1.50-222.54%
AGENAgenus Inc3.01-345.37%
INVAInnoviva Inc3.15-357.14%
VXRTVaxart Inc3.55-389.40%
CRMDCorMedix Inc3.63-395.82%
CVACCureVac N.V.4.45-462.45%
GLPGGalapagos NV4.86-496.14%
SRPTSarepta Therapeutics Inc4.88-498.03%
ABEOAbeona Therapeutics Inc5.39-539.23%
ABUSArbutus Biopharma Corp5.60-556.20%
ZVRAZevra Therapeutics Inc5.89-579.97%
SPROSpero Therapeutics Inc6.23-607.79%
CGENCompugen Ltd6.31-614.76%
RIGLRigel Pharmaceuticals6.87-660.27%
SLXNSilexion Therapeutics Corp7.30-694.84%
OMEROmeros Corporation9.26-854.85%
AUPHAurinia Pharmaceuticals Inc9.58-881.44%
PLXProtalix BioTherapeutics Inc10.89-987.92%
ACADAcadia Pharmaceuticals Inc11.73-1056.21%
TBPHTheravance Biopharma Inc12.26-1099.71%
ADMAAdma Biologics Inc12.42-1112.43%
HRMYHarmony Biosciences Holdings Inc13.82-1226.74%
SABSSAB Biotherapeutics Inc14.14-1252.50%
NAGENiagen Bioscience Inc14.82-1308.10%
INCYIncyte Corp15.82-1389.99%
REGNRegeneron Pharmaceuticals Inc15.86-1392.77%
PBYIPuma Biotechnology Inc17.32-1511.72%
CPRXCatalyst Pharmaceuticals Inc17.44-1521.80%
EXELExelixis Inc17.54-1529.85%
TGTXTG Therapeutics Inc18.97-1646.27%
MDXGMimedx Group Inc20.55-1775.61%
XOMAXOMA Royalty Corp22.87-1964.99%
ARGXArgen X SE24.30-2081.03%
CTMXCytomX Therapeutics Inc24.82-2123.68%
XOMAOXOMA Royalty Corp25.34-2166.38%
HALOHalozyme Therapeutics Inc25.62-2189.12%
XOMAPXOMA Royalty Corp25.67-2192.90%
VRTXVertex Pharmaceuticals Inc27.99-2382.43%
RPRXRoyalty Pharma plc - Class A28.69-2438.91%
SLNOSoleno Therapeutics Inc29.02-2465.64%
ASNDAscendis Pharma A/S30.09-2552.89%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3190.99%
APLSApellis Pharmaceuticals Inc39.02-3281.42%
BMRNBiomarin Pharmaceutical Inc42.21-3541.56%
KRYSKrystal Biotech Inc45.34-3796.88%
ONCBeiGene Ltd69.54-5769.68%
PHARPharming Group N.V.75.03-6216.88%
TECHBio-Techne Corp101.96-8412.73%
VCELVericel Corp109.92-9061.96%
ALNYAlnylam Pharmaceuticals Inc117.96-9717.77%
GMABGenmab140.29-11538.00%
TLXTelix Pharmaceuticals Ltd162.15-13320.43%
CORTCorcept Therapeutics Inc212.86-17454.41%